SAN FRANCISCO--(BUSINESS WIRE)--Bridge Pharmaceuticals announced today that Dr. Wan Yang Feng has been appointed Director of Bioanalytic and Metabolism in its Beijing subsidiary effective immediately. Dr. Feng’s areas of responsibility will include analytic methods development and validation, metabolic profiling of new pharmaceutical drugs, drug-drug interactions, and adsorption and general pharmacology assessment.
